KIAA1549 and pilomyxoid astrocytoma: Hawkins et al. later found that the KIAA1549:BRAF fusion was an independent prognostic marker for significantly improved 5 year PFS for pilocytic astrocytomas as well as Grade II diffuse and pilomyxoid astrocytomas (156).